Caraco Pharmaceutical Laboratories Ltd. Long Term Shareholder Investigation

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) October 9, 2009 -- SAN DIEGO, CA (Shareholders Foundation) – An investigation on behalf of long term investors of Caraco Pharmaceutical Laboratories Ltd. (Public, AMEX:CPD), who currently hold their CPD shares, over potential claims against Caraco Pharmaceutical Laboratories, Ltd. (AMEX:CPD) and others, concerning possible securities violations related to public statements made by the Company between May 29, 2008 and June 25, 2009 was announced.

Those who are long term investors in Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD) and/or purchased Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD) shares between May 29, 2008 and June 25, 2009, have certain options and should contact the Shareholders Foundation, Inc at:

Email: mail@shareholdersfoundation.com

Or call us at: +1 (858) 779 - 1554

Caraco Pharmaceutical Laboratories has been accused of alleged securities laws violations. An investor in Caraco Pharmaceutical Laboratories has filed a proposed securities class action lawsuit in the United States District Court for the Eastern District of Michigan behalf of certain investors of Caraco Pharmaceutical Laboratories Ltd. (Public, AMEX:CPD) over potential claims against Caraco Pharmaceutical Laboratories, Ltd. (AMEX:CPD), concerning possible securities violations related to public statements made by the Company between May 29, 2008 and June 25, 2009. According to the complaint the plaintiff alleges that Caraco Pharmaceutical Laboratories and certain of the its executive officers violated federal securities laws by knowing or recklessly disregarding May 29, 2008 and June 25, 2009 that their public statements concerning Caraco Pharmaceutical Laboratories’s business, operations, and prospects were materially false and misleading. U.S. authorities have seized all medicines produced by generic drug maker Caraco Pharmaceutical Laboratories Ltd (CPD.A) following repeated violations of manufacturing standards according to health officials. Subsequently an investigation by a law firm on behalf of long term investors concerning allegedly false and misleading statements and material omissions between May 29, 2008 and June 25, 2009 by Caraco Pharmaceutical, and reports that on June 25, 2009 was announced. Caraco Pharmaceutical Laboratories, Ltd. announced on Thursday, June 25, 2009, that U.S. Marshals, at the request of the FDA, arrived and seized drug products manufactured in its Michigan facilities and that the seizure also included ingredients held at these same facilities, but that products distributed by Caraco that are manufactured outside of these facilities are not impacted. The FDA's inspection of Caraco Pharmaceutical Laboratories, Ltd.'s Detroit facility, completed in May 2009, found unresolved violations of cGMP requirements as previously disclosed in last SEC filing on Form 10-K filed June 15, 2009, so Caraco Pharmaceuticals in its press release. ...

AMEX CPD     business     Caraco     Caraco Pharmaceutical     cpd     finance